SUBSCRIPTION AGREEMENT between THE SUBSCRIBER LISTED IN THE SCHEDULE OF PARTICULARS and PSYENCE LABS LTD. WHEREBY THE PARTIES AGREE AS FOLLOWS - 1 INTERPRETATION 1.1 In this Agreement - 1.1.1 clause headings are for conv
Friday, September 5, 2025 BiopharmaWatch Research 1 min read
Key Takeaway: Psyence Labs Ltd. has formalized a subscription agreement with Psyence Biomed II Corp., which involves the issuance of 1,750 shares at a total subscription price of $3,500,000. The agreement was signed by authorized representatives from both parties, marking a significant investment into Psyence Labs. This collaboration indicates ongoing confidence in the company's strategic direction and market potential.
Price reaction · baseline $16.125 (2025-09-04 close) · hit after-hours · clean, no other PBM news in the window
day 0 close · peak
+4.3%
Market Sentiment Analysis
POSITIVE FACTORS
Psyence Labs Ltd. has secured a significant investment with the subscription agreement.
The agreement indicates confidence in the company's future by the subscriber.
Total subscription amount of $3,500,000 reflects strong financial backing.